Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
SUMOylation is a Therapeutic Vulnerability in High-risk Neuroblastoma
HTML
Details
Locations
Year:
2026
Type:
preprint
Source:
bioRxiv (Cold Spring Harbor Laboratory)
DOI:
10.64898/2026.09.05.749647
Authors:
Antti Kukkula,
Saiganesh Sriraman,
Verneri Virtanen,
Sara L. M. Kuusela,
Lara Kozina Bubnič,
Ilkka Paatero,
Vilja Pietiäinen,
Daniel Bexell,
Maria Sundvall
show all 9
Institutions:
University of Turku,
Turku University Hospital,
University of Helsinki,
Institute for Molecular Medicine Finland,
HiLIFE – Elämäntieteiden Instituutti,
University of Ljubljana,
Åbo Akademi University,
Lund University
show all 8
Language:
English
Topic:
Neuroblastoma Research and Treatments
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W7212172324
Cites:
66
Cited by:
Related to:
10